Psa and Klk2 As Therapeutic Targets and Molecules Inhibiting Psa and Klk2

Disclosed herein are compositions and methods relating to prostate-specific antigen (PSA), KLK2 and androgen receptor. Further provided are methods and compositions for inhibiting PSA and/or KLK2 activity. Further provided are compositions and methods for treating or preventing cancer.

Attached files:
EP 2315846.jpg

Patents:
EP 2,315,846

Inventor(s): CHANG CHAWNSHANG [US]

Type of Offer: Licensing

Contact Patent Owner or Broker


Next Patent »
« More Biotech Patents

Share on      

CrowdSell Your Patent